subject area of
- A Multimaterial Microphysiological Platform Enabled by Rapid Casting of Elastic Microwires Journal Articles
- AMP-activated protein kinase: the current landscape for drug development Journal Articles
- Challenges in the prevention or treatment of RSV with emerging new agents in children from low- and middle-income countries Journal Articles
- Current models of pulmonary fibrosis for future drug discovery efforts Journal Articles
- Development of Potent Forchlorfenuron Analogs and Their Cytotoxic Effect in Cancer Cell Lines. Journal Articles
- Drug related adverse event assessment in neonates in clinical trials and clinical care Journal Articles
- Emerging therapeutic targets for idiopathic pulmonary fibrosis: preclinical progress and therapeutic implications Journal Articles
- Engineered organoids for biomedical applications Journal Articles
- Estimating the clinical cost of drug development for orphan versus non-orphan drugs Journal Articles
- Ethics of controlled human infection to address COVID-19 Journal Articles
- Human pluripotent stem cell (hPSC)-derived models for autism spectrum disorder drug discovery. Journal Articles
- Model‐Informed Drug Development for Anti‐Infectives: State of the Art and Future Journal Articles
- Pediatric drug data in Canadian drug monographs: a descriptive analysis Journal Articles
- Regional Approaches to Expedited Drug Development and Review: Can Regulatory Harmonization Improve Outcomes? Journal Articles
- Seamless Designs: Current Practice and Considerations for Early-Phase Drug Development in Oncology Journal Articles
- Synthesis of α-methylstilbenes using an aqueous Wittig methodology and application toward the development of potent human aromatase inhibitors Journal Articles
- The Therapeutic Pipeline for Pseudomonas aeruginosa Infections Journal Articles
- The role of early-phase trials and real-world evidence in drug development Journal Articles
- Therapeutic Strategies and Drug Development for Vascular Cognitive Impairment Journal Articles
- Therapeutic targets and early stage clinical trials for pulmonary fibrosis Journal Articles
- Third human challenge trial conference, Oxford, United Kingdom, February 6–7, 2020, a meeting report Journal Articles
- Treatment of idiopathic pulmonary fibrosis: an update on emerging drugs in phase II & III clinical trials Journal Articles
- What have we learned from basic science studies on idiopathic pulmonary fibrosis? Journal Articles